MUC5AC content and secretion in IL-13-stimulated airway cultures
Cell-based study · Primary human tracheal-bronchial epithelial cultures (MatTek EpiAirway), differentiated at air–liquid interface; a single donor. [1]
Basolateral guaifenesin reduced MUC5AC secretion and cellular content. WST-1 comparisons found no significant viability change versus IL-13 alone. Quadruplicate cultures per condition/time are culture replicates from one donor, not four donors.
| Endpoint | Reported result | Reference |
|---|---|---|
| MUC5AC in pooled apical washes at 24 hr | IC50 (95% CI) 96 (85–109) μM | [1] |
| Cellular MUC5AC content at 24 hr | IC50 (95% CI) 150 (95–330) μM | [1] |
| Cell viability at 3, 8 and 24 hr | Statistical comparison No significant change versus IL-13-only control | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 10, 30, 100 and 300 μM guaifenesin; IL-13 1 ng/mL
- Exposure duration
- 3, 8 or 24 hr after 3 days of IL-13 pre-treatment; IC50 estimates selected only at 24 hr.
- Method
- Basolateral addition; IL-13 continued. Apical surfaces washed immediately before drug exposure. Controls: IL-13 alone and neither IL-13 nor drug.
- Vehicle
- Culture medium
- Co-treatment
- IL-13 stimulation; NAC and ambroxol were separate comparator treatments, not co-administered with guaifenesin.
- Reported limits
- Reagent purity and stereochemical composition not specified in read methods. No donor replication.
Methods and source locations
Compound reported in the paper: Guaifenesin; Compound label in the paper: GGE
Evidence concerns the reported guaifenesin reagent, not an Adooq lot or a clinical formulation.
Materials and methods: Cell cultures and exposures; Cell viability and cellular levels and release of MUC5AC; MUC5AC ELISA; Statistical analysis; Results: Viability and MUC5AC secretion and content; Figures 3–5
MUC5AC in pooled apical washes at 24 hr: MUC5AC ELISA; exponential-decay fit — Results: MUC5AC secretion and content; Figure 4, 24 hr; Statistical analysis
Cellular MUC5AC content at 24 hr: MUC5AC ELISA in lysates; exponential-decay fit — Results: MUC5AC secretion and content; Figure 5, 24 hr
Cell viability at 3, 8 and 24 hr: WST-1; ANOVA with Dunnett’s post-test — Results: Viability; Figure 3